Showing results (31-40 of 185) with videos related to
Sort By:
Pageof 19
Journal of Alzheimer'S Disease : JAD|June 14, 2024
Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's DiseaseAnas Shamsi, Mohammad Furkan, Mohd Shahnawaz Khan, et al.International Journal of Biological Macromolecules|March 5, 2022
Role of polyphenols in combating Type 2 Diabetes and insulin resistanceMoyad Shahwan, Fahad Alhumaydhi, Ghulam Md Ashraf, et al.Heliyon|May 26, 2023
In vitro and In vivo study targeting the development of Unani Antidermatophytic Cream: Implication of Herbal Formulations in Treatment of DermatophytosisHina Anjum, Ghulamuddin Sofi, Moyad Shahwan, et al.Frontiers in Molecular Biosciences|May 1, 2025
Structure-guided virtual screening reveals phytoconstituents as potent cathepsin B inhibitors: Implications for cancer, traumatic brain injury, and Alzheimer's diseaseNageeb Hassan, Mohammad Furkan, Mohd Shahnawaz Khan, et al.Journal of Ethnopharmacology|November 12, 2002
Effect of khat, its constituents and restraint stress on free radical metabolism of ratsTariq M Al-Qirim, Moyad Shahwan, Kashif R Zaidi, et al.Molecular Neurobiology|October 21, 2023
Implication of Caffeic Acid for the Prevention and Treatment of Alzheimer's Disease: Understanding the Binding with Human Transferrin Using In Silico and In Vitro ApproachesAnas Shamsi, Moyad Shahwan, Debarati Das Gupta, et al.Heliyon|December 15, 2025
Retraction notice to "In vitro and In vivo study targeting the development of Unani Antidermatophytic Cream: Implication of Herbal Formulations in Treatment of Dermatophytosis" [Heliyon 9 (2023) e16154]Hina Anjum, Ghulamuddin Sofi, Moyad Shahwan, et al.Plos One|November 10, 2022
Development and validation of a novel cosmetics safety assessment scale (CSAS): Factual understanding of cosmetic safety and fostering international awarenessAmmar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, et al.Journal of Biomolecular Structure & Dynamics|February 19, 2024
Unlocking therapeutic potential: computational insights into TREM2 protein targeting with FDA-approved drugs for neurodegenerationMohammed Alrouji, Sabina Yasmin, Fahad A Alhumaydhi, et al.Frontiers in Chemistry|August 13, 2024
ROS1 kinase inhibition reimagined: identifying repurposed drug via virtual screening and molecular dynamics simulations for cancer therapeuticsMohammed Alrouji, Sabina Yasmin, Fahad A Alhumaydhi, et al.Pageof 19